1 Ophthalmic Anti-inflammatories Market Overview 1.1 Product Overview and Scope of Ophthalmic Anti-inflammatories 1.2 Ophthalmic Anti-inflammatories Segment by Type 1.2.1 Global Ophthalmic Anti-inflammatories Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Antibacterial 1.2.3 Antiviral 1.2.4 Antifungal 1.2.5 Anti-Parasitic 1.2.6 Others 1.3 Ophthalmic Anti-inflammatories Segment by Application 1.3.1 Global Ophthalmic Anti-inflammatories Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Ophthalmic Anti-inflammatories Market Size Estimates and Forecasts 1.4.1 Global Ophthalmic Anti-inflammatories Revenue 2017-2028 1.4.2 Global Ophthalmic Anti-inflammatories Sales 2017-2028 1.4.3 Ophthalmic Anti-inflammatories Market Size by Region: 2017 Versus 2021 Versus 2028 2 Ophthalmic Anti-inflammatories Market Competition by Manufacturers 2.1 Global Ophthalmic Anti-inflammatories Sales Market Share by Manufacturers (2017-2022) 2.2 Global Ophthalmic Anti-inflammatories Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Ophthalmic Anti-inflammatories Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Ophthalmic Anti-inflammatories Manufacturing Sites, Area Served, Product Type 2.5 Ophthalmic Anti-inflammatories Market Competitive Situation and Trends 2.5.1 Ophthalmic Anti-inflammatories Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Ophthalmic Anti-inflammatories Players Market Share by Revenue 2.5.3 Global Ophthalmic Anti-inflammatories Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Ophthalmic Anti-inflammatories Retrospective Market Scenario by Region 3.1 Global Ophthalmic Anti-inflammatories Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Ophthalmic Anti-inflammatories Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Ophthalmic Anti-inflammatories Market Facts & Figures by Country 3.3.1 North America Ophthalmic Anti-inflammatories Sales by Country 3.3.2 North America Ophthalmic Anti-inflammatories Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Ophthalmic Anti-inflammatories Market Facts & Figures by Country 3.4.1 Europe Ophthalmic Anti-inflammatories Sales by Country 3.4.2 Europe Ophthalmic Anti-inflammatories Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Ophthalmic Anti-inflammatories Market Facts & Figures by Region 3.5.1 Asia Pacific Ophthalmic Anti-inflammatories Sales by Region 3.5.2 Asia Pacific Ophthalmic Anti-inflammatories Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Ophthalmic Anti-inflammatories Market Facts & Figures by Country 3.6.1 Latin America Ophthalmic Anti-inflammatories Sales by Country 3.6.2 Latin America Ophthalmic Anti-inflammatories Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Ophthalmic Anti-inflammatories Market Facts & Figures by Country 3.7.1 Middle East and Africa Ophthalmic Anti-inflammatories Sales by Country 3.7.2 Middle East and Africa Ophthalmic Anti-inflammatories Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Ophthalmic Anti-inflammatories Historic Market Analysis by Type 4.1 Global Ophthalmic Anti-inflammatories Sales Market Share by Type (2017-2022) 4.2 Global Ophthalmic Anti-inflammatories Revenue Market Share by Type (2017-2022) 4.3 Global Ophthalmic Anti-inflammatories Price by Type (2017-2022) 5 Global Ophthalmic Anti-inflammatories Historic Market Analysis by Application 5.1 Global Ophthalmic Anti-inflammatories Sales Market Share by Application (2017-2022) 5.2 Global Ophthalmic Anti-inflammatories Revenue Market Share by Application (2017-2022) 5.3 Global Ophthalmic Anti-inflammatories Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Novartis 6.1.1 Novartis Corporation Information 6.1.2 Novartis Description and Business Overview 6.1.3 Novartis Ophthalmic Anti-inflammatories Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Novartis Ophthalmic Anti-inflammatories Product Portfolio 6.1.5 Novartis Recent Developments/Updates 6.2 Valeant Pharmaceuticals 6.2.1 Valeant Pharmaceuticals Corporation Information 6.2.2 Valeant Pharmaceuticals Description and Business Overview 6.2.3 Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Product Portfolio 6.2.5 Valeant Pharmaceuticals Recent Developments/Updates 6.3 Allergan 6.3.1 Allergan Corporation Information 6.3.2 Allergan Description and Business Overview 6.3.3 Allergan Ophthalmic Anti-inflammatories Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Allergan Ophthalmic Anti-inflammatories Product Portfolio 6.3.5 Allergan Recent Developments/Updates 6.4 Santen Pharmaceutical 6.4.1 Santen Pharmaceutical Corporation Information 6.4.2 Santen Pharmaceutical Description and Business Overview 6.4.3 Santen Pharmaceutical Ophthalmic Anti-inflammatories Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Santen Pharmaceutical Ophthalmic Anti-inflammatories Product Portfolio 6.4.5 Santen Pharmaceutical Recent Developments/Updates 6.5 Lupin Pharmaceuticals 6.5.1 Lupin Pharmaceuticals Corporation Information 6.5.2 Lupin Pharmaceuticals Description and Business Overview 6.5.3 Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Product Portfolio 6.5.5 Lupin Pharmaceuticals Recent Developments/Updates 6.6 Apotex 6.6.1 Apotex Corporation Information 6.6.2 Apotex Description and Business Overview 6.6.3 Apotex Ophthalmic Anti-inflammatories Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Apotex Ophthalmic Anti-inflammatories Product Portfolio 6.6.5 Apotex Recent Developments/Updates 6.7 Akorn 6.6.1 Akorn Corporation Information 6.6.2 Akorn Description and Business Overview 6.6.3 Akorn Ophthalmic Anti-inflammatories Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Akorn Ophthalmic Anti-inflammatories Product Portfolio 6.7.5 Akorn Recent Developments/Updates 7 Ophthalmic Anti-inflammatories Manufacturing Cost Analysis 7.1 Ophthalmic Anti-inflammatories Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Ophthalmic Anti-inflammatories 7.4 Ophthalmic Anti-inflammatories Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Ophthalmic Anti-inflammatories Distributors List 8.3 Ophthalmic Anti-inflammatories Customers 9 Ophthalmic Anti-inflammatories Market Dynamics 9.1 Ophthalmic Anti-inflammatories Industry Trends 9.2 Ophthalmic Anti-inflammatories Market Drivers 9.3 Ophthalmic Anti-inflammatories Market Challenges 9.4 Ophthalmic Anti-inflammatories Market Restraints 10 Global Market Forecast 10.1 Ophthalmic Anti-inflammatories Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Ophthalmic Anti-inflammatories by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Ophthalmic Anti-inflammatories by Type (2023-2028) 10.2 Ophthalmic Anti-inflammatories Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Ophthalmic Anti-inflammatories by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Ophthalmic Anti-inflammatories by Application (2023-2028) 10.3 Ophthalmic Anti-inflammatories Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Ophthalmic Anti-inflammatories by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Ophthalmic Anti-inflammatories by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Ophthalmic Anti-inflammatories Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Ophthalmic Anti-inflammatories Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Ophthalmic Anti-inflammatories Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Ophthalmic Anti-inflammatories Market Competitive Situation by Manufacturers in 2021 Table 5. Global Ophthalmic Anti-inflammatories Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Ophthalmic Anti-inflammatories Sales Market Share by Manufacturers (2017-2022) Table 7. Global Ophthalmic Anti-inflammatories Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Ophthalmic Anti-inflammatories Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Ophthalmic Anti-inflammatories Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Ophthalmic Anti-inflammatories Manufacturing Sites and Area Served Table 11. Manufacturers Ophthalmic Anti-inflammatories Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ophthalmic Anti-inflammatories by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Anti-inflammatories as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Ophthalmic Anti-inflammatories Sales by Region (2017-2022) & (K Units) Table 16. Global Ophthalmic Anti-inflammatories Sales Market Share by Region (2017-2022) Table 17. Global Ophthalmic Anti-inflammatories Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Ophthalmic Anti-inflammatories Revenue Market Share by Region (2017-2022) Table 19. North America Ophthalmic Anti-inflammatories Sales by Country (2017-2022) & (K Units) Table 20. North America Ophthalmic Anti-inflammatories Sales Market Share by Country (2017-2022) Table 21. North America Ophthalmic Anti-inflammatories Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Ophthalmic Anti-inflammatories Revenue Market Share by Country (2017-2022) Table 23. Europe Ophthalmic Anti-inflammatories Sales by Country (2017-2022) & (K Units) Table 24. Europe Ophthalmic Anti-inflammatories Sales Market Share by Country (2017-2022) Table 25. Europe Ophthalmic Anti-inflammatories Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Ophthalmic Anti-inflammatories Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Ophthalmic Anti-inflammatories Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Ophthalmic Anti-inflammatories Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Ophthalmic Anti-inflammatories Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Ophthalmic Anti-inflammatories Revenue Market Share by Region (2017-2022) Table 31. Latin America Ophthalmic Anti-inflammatories Sales by Country (2017-2022) & (K Units) Table 32. Latin America Ophthalmic Anti-inflammatories Sales Market Share by Country (2017-2022) Table 33. Latin America Ophthalmic Anti-inflammatories Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Ophthalmic Anti-inflammatories Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Ophthalmic Anti-inflammatories Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Ophthalmic Anti-inflammatories Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Ophthalmic Anti-inflammatories Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Ophthalmic Anti-inflammatories Revenue Market Share by Country (2017-2022) Table 39. Global Ophthalmic Anti-inflammatories Sales by Type (2017-2022) & (K Units) Table 40. Global Ophthalmic Anti-inflammatories Sales Market Share by Type (2017-2022) Table 41. Global Ophthalmic Anti-inflammatories Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Ophthalmic Anti-inflammatories Revenue Share by Type (2017-2022) Table 43. Global Ophthalmic Anti-inflammatories Price by Type (2017-2022) & (US$/Unit) Table 44. Global Ophthalmic Anti-inflammatories Sales (K Units) by Application (2017-2022) Table 45. Global Ophthalmic Anti-inflammatories Sales Market Share by Application (2017-2022) Table 46. Global Ophthalmic Anti-inflammatories Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Ophthalmic Anti-inflammatories Revenue Share by Application (2017-2022) Table 48. Global Ophthalmic Anti-inflammatories Price by Application (2017-2022) & (US$/Unit) Table 49. Novartis Corporation Information Table 50. Novartis Description and Business Overview Table 51. Novartis Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Novartis Ophthalmic Anti-inflammatories Product Table 53. Novartis Recent Developments/Updates Table 54. Valeant Pharmaceuticals Corporation Information Table 55. Valeant Pharmaceuticals Description and Business Overview Table 56. Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Product Table 58. Valeant Pharmaceuticals Recent Developments/Updates Table 59. Allergan Corporation Information Table 60. Allergan Description and Business Overview Table 61. Allergan Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Allergan Ophthalmic Anti-inflammatories Product Table 63. Allergan Recent Developments/Updates Table 64. Santen Pharmaceutical Corporation Information Table 65. Santen Pharmaceutical Description and Business Overview Table 66. Santen Pharmaceutical Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Santen Pharmaceutical Ophthalmic Anti-inflammatories Product Table 68. Santen Pharmaceutical Recent Developments/Updates Table 69. Lupin Pharmaceuticals Corporation Information Table 70. Lupin Pharmaceuticals Description and Business Overview Table 71. Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Product Table 73. Lupin Pharmaceuticals Recent Developments/Updates Table 74. Apotex Corporation Information Table 75. Apotex Description and Business Overview Table 76. Apotex Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Apotex Ophthalmic Anti-inflammatories Product Table 78. Apotex Recent Developments/Updates Table 79. Akorn Corporation Information Table 80. Akorn Description and Business Overview Table 81. Akorn Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Akorn Ophthalmic Anti-inflammatories Product Table 83. Akorn Recent Developments/Updates Table 84. Production Base and Market Concentration Rate of Raw Material Table 85. Key Suppliers of Raw Materials Table 86. Ophthalmic Anti-inflammatories Distributors List Table 87. Ophthalmic Anti-inflammatories Customers List Table 88. Ophthalmic Anti-inflammatories Market Trends Table 89. Ophthalmic Anti-inflammatories Market Drivers Table 90. Ophthalmic Anti-inflammatories Market Challenges Table 91. Ophthalmic Anti-inflammatories Market Restraints Table 92. Global Ophthalmic Anti-inflammatories Sales Forecast by Type (2023-2028) & (K Units) Table 93. Global Ophthalmic Anti-inflammatories Sales Market Share Forecast by Type (2023-2028) Table 94. Global Ophthalmic Anti-inflammatories Revenue Forecast by Type (2023-2028) & (US$ Million) Table 95. Global Ophthalmic Anti-inflammatories Revenue Market Share Forecast by Type (2023-2028) Table 96. Global Ophthalmic Anti-inflammatories Sales Forecast by Application (2023-2028) & (K Units) Table 97. Global Ophthalmic Anti-inflammatories Sales Market Share Forecast by Application (2023-2028) Table 98. Global Ophthalmic Anti-inflammatories Revenue Forecast by Application (2023-2028) & (US$ Million) Table 99. Global Ophthalmic Anti-inflammatories Revenue Market Share Forecast by Application (2023-2028) Table 100. Global Ophthalmic Anti-inflammatories Sales Forecast by Region (2023-2028) & (K Units) Table 101. Global Ophthalmic Anti-inflammatories Sales Market Share Forecast by Region (2023-2028) Table 102. Global Ophthalmic Anti-inflammatories Revenue Forecast by Region (2023-2028) & (US$ Million) Table 103. Global Ophthalmic Anti-inflammatories Revenue Market Share Forecast by Region (2023-2028) Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ophthalmic Anti-inflammatories Figure 2. Global Ophthalmic Anti-inflammatories Market Share by Type in 2021 & 2028 Figure 3. Antibacterial Product Picture Figure 4. Antiviral Product Picture Figure 5. Antifungal Product Picture Figure 6. Anti-Parasitic Product Picture Figure 7. Others Product Picture Figure 8. Global Ophthalmic Anti-inflammatories Market Share by Application in 2021 & 2028 Figure 9. Hospital Figure 10. Clinic Figure 11. Others Figure 12. Global Ophthalmic Anti-inflammatories Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Ophthalmic Anti-inflammatories Market Size (2017-2028) & (US$ Million) Figure 14. Global Ophthalmic Anti-inflammatories Sales (2017-2028) & (K Units) Figure 15. Ophthalmic Anti-inflammatories Sales Share by Manufacturers in 2021 Figure 16. Global Ophthalmic Anti-inflammatories Revenue Share by Manufacturers in 2021 Figure 17. The Global 5 and 10 Largest Ophthalmic Anti-inflammatories Players: Market Share by Revenue in 2021 Figure 18. Ophthalmic Anti-inflammatories Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 19. Global Ophthalmic Anti-inflammatories Sales Market Share by Region (2017-2022) Figure 20. Global Ophthalmic Anti-inflammatories Sales Market Share by Region in 2021 Figure 21. Global Ophthalmic Anti-inflammatories Revenue Market Share by Region (2017-2022) Figure 22. Global Ophthalmic Anti-inflammatories Revenue Market Share by Region in 2021 Figure 23. United States Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Canada Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Germany Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. France Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. U.K. Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Italy Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Russia Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. China Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Japan Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. South Korea Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. India Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Australia Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. China Taiwan Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Indonesia Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Thailand Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Malaysia Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Ophthalmic Anti-inflammatories Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Ophthalmic Anti-inflammatories by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Ophthalmic Anti-inflammatories Figure 47. Manufacturing Process Analysis of Ophthalmic Anti-inflammatories Figure 48. Ophthalmic Anti-inflammatories Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Novartis Valeant Pharmaceuticals Allergan Santen Pharmaceutical Lupin Pharmaceuticals Apotex Akorn